Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia
Clinical trial NCT00041379 · UNKNOWN
Trial details
- NCT number
- NCT00041379
- Sponsor
- LifeTime Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.